SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-026889
Filing Date
2024-08-14
Accepted
2024-08-14 17:28:23
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ctdh20240630_10q.htm   iXBRL 10-Q 876347
2 EXHIBIT 31.1 ex_711652.htm EX-31.1 12368
3 EXHIBIT 31.2 ex_711654.htm EX-31.2 12386
4 EXHIBIT 32.1 ex_711655.htm EX-32.1 4755
5 EXHIBIT 32.2 ex_711656.htm EX-32.2 4869
  Complete submission text file 0001437749-24-026889.txt   4701562

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20240630.xsd EX-101.SCH 44990
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20240630_def.xml EX-101.DEF 330167
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20240630_lab.xml EX-101.LAB 263521
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20240630_pre.xml EX-101.PRE 348890
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctdh-20240630_cal.xml EX-101.CAL 32544
66 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20240630_10q_htm.xml XML 650519
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39780 | Film No.: 241209705
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)